hotspot -WSS

hotspot

author：hotspot 2025-10-01 02:15:38 - browse：3

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： How a small hospital in rural Puerto Rico survived Hurricane Maria

Wikipedia

WSS

Ultragenyx gene therapy for rare liver ailment succeeds in late

AI for drug discovery: Experts on separating hype from reality

AltruBio raises $225 million to develop ulcerative colitis drug

Kaiser's Risant Health gobbled up Geisinger. Who is next?

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Let's speed up science by embracing open access publishing

focus

hotspot

explore

Medicare proposal to cover medical devices draws a mixed reaction

Brain MRIs reveal impact of 'toxic stress' on Black children

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

Supreme Court strikes down use of affirmative action

The effects of a landmark ruling on DNA ownership are becoming clearer

Activists slam private health insurers over coverage restrictions

How a small hospital in rural Puerto Rico survived Hurricane Maria

Trump demands the U.S. pay no more for drugs than other countries … again

HIV drugs protect against transmission, even in unprotected sex

hotspot

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Ionis drug prevents swelling attacks due to hereditary angioedema

Woman returns to dialysis after doctors remove transplanted pig kidney

Brain technologies pose threats that are all too real, experts warn

Woman returns to dialysis after doctors remove transplanted pig kidney

Can gargling with Listerine treat gonorrhea of the mouth?

Wikipedia

entertainment

explore

explore